Articles with public access mandates - Maximilian DiehnLearn more
Not available anywhere: 12
Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy
EL Pollom, AL Chin, M Diehn, BW Loo, DT Chang
Seminars in radiation oncology 27 (3), 197-208, 2017
Mandates: US National Institutes of Health
Circulating tumor DNA testing in advanced non-small cell lung cancer
EJ Moding, M Diehn, HA Wakelee
Lung Cancer 119, 42-47, 2018
Mandates: US National Institutes of Health
Identification and genetic manipulation of human and mouse oesophageal stem cells
Y Jeong, H Rhee, S Martin, D Klass, Y Lin, W Feng, M Diehn
Gut 65 (7), 1077-1086, 2016
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation
Hypofractionated intensity-modulated radiotherapy for patients with non–small-cell lung cancer
EL Pollom, Y Qian, BY Durkee, R von Eyben, PG Maxim, DB Shultz, ...
Clinical Lung Cancer 17 (6), 588-594, 2016
Mandates: US National Institutes of Health
Stem cells, cell differentiation, and cancer
P Dalerba, M Diehn, IL Weissman, MF Clarke
Abeloff's Clinical Oncology, 97-107. e5, 2020
Mandates: US Department of Defense, US National Institutes of Health, Doris Duke …
Predictors of respiratory decline following stereotactic ablative radiotherapy to multiple lung tumors
EJ Moding, R Liang, FM Lartey, PG Maxim, A Sung, M Diehn, BW Loo Jr, ...
Clinical lung cancer 20 (6), 461-468. e2, 2019
Mandates: UK Medical Research Council
Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors
Y Qian, H Zhu, EL Pollom, BY Durkee, AA Chaudhuri, MF Gensheimer, ...
Practical Radiation Oncology 7 (6), e525-e529, 2017
Mandates: US National Institutes of Health
SU‐D‐17A‐04: The Impact of Audiovisual Biofeedback On Image Quality During 4D Functional and Anatomic Imaging: Results of a Prospective Clinical Trial
P Keall, J Yang, T Yamamoto, S Pollock, M Diehn, J Berger, E Graves, ...
Medical Physics 41 (6Part3), 117-117, 2014
Mandates: US National Institutes of Health, National Health and Medical Research …
MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS.
M Roschewski, DM Kurtz, J Westin, RC Lynch, SK Alig, C Macaulay, ...
Hematological Oncology 41, 2023
Mandates: US National Institutes of Health
A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans
DW Pinkham, M Negahdar, T Yamamoto, E Mittra, M Diehn, VS Nair, ...
Academic radiology 26 (1), 38-49, 2019
Mandates: US National Institutes of Health
Acute and late esophageal toxicity after SABR to thoracic tumors near or abutting the esophagus
QH Sodji, R Ko, R von Eyben, SG Owen, DPI Capaldi, K Bush, MS Binkley, ...
International Journal of Radiation Oncology* Biology* Physics 112 (5), 1144-1153, 2022
Mandates: US National Institutes of Health
Distinct molecular determinants of treatment‐failure in elderly Hodgkin lymphoma identified by cell‐free DNA profiling: A LYSA Study.
C Rossi, JL Boegeholz, SK Alig, A Garofolo, MS Esfahani, ...
Hematological Oncology 41, 2023
Mandates: US National Institutes of Health
Available somewhere: 115
Robust enumeration of cell subsets from tissue expression profiles
AM Newman, CL Liu, MR Green, AJ Gentles, W Feng, Y Xu, CD Hoang, ...
Nature methods 12 (5), 453-457, 2015
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation, Damon …
The prognostic landscape of genes and infiltrating immune cells across human cancers
AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim, VS Nair, ...
Nature medicine 21 (8), 938-945, 2015
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation, V …
Association of reactive oxygen species levels and radioresistance in cancer stem cells
M Diehn, RW Cho, NA Lobo, T Kalisky, MJ Dorie, AN Kulp, D Qian, ...
nature 458 (7239), 780-783, 2009
Mandates: US National Institutes of Health
Determining cell type abundance and expression from bulk tissues with digital cytometry
AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ...
Nature biotechnology 37 (7), 773-782, 2019
Mandates: US Department of Defense, US National Institutes of Health, V Foundation …
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ...
Nature medicine 20 (5), 548-554, 2014
Mandates: US National Institutes of Health
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
Y Shimono, M Zabala, RW Cho, N Lobo, P Dalerba, D Qian, M Diehn, ...
cell 138 (3), 592-603, 2009
Mandates: US National Institutes of Health
Integrated digital error suppression for improved detection of circulating tumor DNA
AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ...
Nature biotechnology 34 (5), 547-555, 2016
Mandates: US National Institutes of Health, V Foundation, USA, Damon Runyon Cancer …
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program